Background
Evidence-based consensus guideline (SSO-ASTRO-ASCO) on surgical margins for BCS with whole-breast irradiation in DCIS. Based on a systematic review and meta-analysis of 20 studies including 7,883 patients with DCIS treated with BCS + RT. Developed to address controversy over the optimal margin width for DCIS after BCS with RT.
Interventions and follow up
Arm A: N/A — consensus guideline, not an RCT
Arm B: N/A
Primary endpoint: Ipsilateral breast tumor recurrence (IBTR) by margin width
mFollow up: Variable (across included studies)
Arm B: N/A
Primary endpoint: Ipsilateral breast tumor recurrence (IBTR) by margin width
mFollow up: Variable (across included studies)
Results
2 mm vs <2 mm margins: 2 mm margins associated with significantly lower IBTR (OR 0.53, P=.001) compared to margins <2 mm
>2 mm margins: No further significant reduction in IBTR compared to 2 mm margins
Negative margins (>0 mm) vs positive: 2-fold increase in IBTR with positive margins
>2 mm margins: No further significant reduction in IBTR compared to 2 mm margins
Negative margins (>0 mm) vs positive: 2-fold increase in IBTR with positive margins
Adverse events
Main adverse events: Not applicable. The meta-analysis included outcomes from the included observational studies without systematic AE reporting.
Conclusions
For DCIS treated with BCS followed by whole breast RT, a minimum margin of 2 mm is associated with the lowest IBTR rates and is recommended. Wider margins (>2 mm) do not further reduce IBTR. Positive margins should be re-excised. This represents a higher margin threshold than for invasive cancer, where "no ink on tumor" is the standard.
Key Limitations
Key Limitations: Based on retrospective observational studies rather than RCTs specifically designed to compare margin widths. Margin definitions varied across studies. Not applicable to DCIS treated without RT or to patients undergoing mastectomy. Focused on WBI only; margin recommendations for APBI in DCIS may differ. The 2 mm cutoff is a guideline average, not a strict biological threshold.
Clinical Context
This is a companion guideline to the SSO-ASTRO-ASCO guideline for invasive breast cancer margins (Moran et al, JCO 2014), which recommends "no ink on tumor." For DCIS with RT, the recommended standard is 2 mm. For DCIS without RT, wider margins (>3 mm) are generally preferred. Surgeons and radiation oncologists should use this to guide re-excision decisions and to counsel patients about LR risk stratification.
References